GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Medivolve Inc (NEOE:MEDV) » Definitions » Institutional Ownership

Medivolve (NEOE:MEDV) Institutional Ownership : 41.84% (As of Jun. 23, 2024)


View and export this data going back to 2009. Start your Free Trial

What is Medivolve Institutional Ownership?

Institutional ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Medivolve's institutional ownership is 41.84%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Medivolve's Insider Ownership is 0.00%.

Float Percentage Of Total Shares Outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Medivolve's Float Percentage Of Total Shares Outstanding is 0.00%.


Medivolve Institutional Ownership Historical Data

The historical data trend for Medivolve's Institutional Ownership can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Medivolve Institutional Ownership Chart

Medivolve Historical Data

The historical data trend for Medivolve can be seen below:

2013-09-30 2013-10-31 2013-11-30 2013-12-31 2014-01-31 2014-02-28 2014-03-31 2014-04-30 2014-05-31 2014-06-30
Institutional Ownership 41.84 41.84 41.84 41.84 41.84 41.84 41.84 41.84 41.84 41.84

Medivolve Institutional Ownership Calculation

The percentage of shares that are owned by institutions out of the total shares outstanding.


Medivolve (NEOE:MEDV) Business Description

Traded in Other Exchanges
Address
198 Davenport Road, Toronto, ON, CAN, M5R 1J2
Medivolve Inc is a healthcare technology and services company. It is engaged in finding and developing disruptive technologies, groundbreaking innovations, and partnerships to help combat COVID-19 and transform human health management. The company operated one reportable segment, the COVID Testing facilities across the United States Of America.
Executives
Douglas Sommerville Director, Senior Officer

Medivolve (NEOE:MEDV) Headlines

No Headlines